Abera Bioscience AB (NGM:ABERA)
6.35
+0.15 (2.42%)
At close: Feb 26, 2026
Abera Bioscience AB Revenue
In the year 2025, Abera Bioscience AB had annual revenue of 11.89M SEK, down -18.74%. Abera Bioscience AB had revenue of -902.00K in the quarter ending December 31, 2025.
Revenue
11.89M
Revenue Growth
-18.74%
P/S Ratio
10.69
Revenue / Employee
2.38M
Employees
5
Market Cap
127.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.89M | -2.74M | -18.74% |
| Dec 31, 2024 | 14.63M | 12.11M | 479.60% |
| Dec 31, 2023 | 2.52M | 736.19K | 41.18% |
| Dec 31, 2022 | 1.79M | 609.91K | 51.78% |
| Dec 31, 2021 | 1.18M | 422.43K | 55.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Valuno Group AB | 2.19B |
| Seamless Distribution Systems AB | 193.62M |
| Spotlight Group AB | 114.42M |
| Fable Media Group AB | 65.47M |
| EmbeddedArt Group AB | 55.67M |
| Aquaticus Real Estate AB | 52.80M |
| Amido AB | 44.95M |
| Nowonomics AB | 19.10M |